Fig. 1From: The efficacy and safety of tislelizumab combined with gemcitabine plus cisplatin in the treatment of postoperative patients with muscle-invasive upper tract urothelial carcinomaPatient screening processUTUC: upper tract urothelial carcinomaRNU: radical nephroureterectomyTGC: tislelizumab combined with gemcitabine plus cisplatinGC: gemcitabine plus cisplatinBack to article page